Ispecimen expands human biospecimen offerings for cancer researchers

Lexington, mass., aug. 18, 2021 /prnewswire/ -- ispecimen inc. (nasdaq: ispc), an online marketplace for human biospecimens ("ispecimen" or the "company"), today announced it has grown its cancer-related supplier network despite lockdowns, slowdowns, and sustained concern around the covid-19 pandemic.

ISPC Ratings Summary

ISPC Quant Ranking